Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Older patients sticking to their prostate medication saw lasting health benefits.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Finasteride caused blisters on hands and feet.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Dutasteride may help prevent prostate cancer, but more research is needed.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Ocrelizumab may cause pancreatitis in some patients.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.